News & Events

• April 27, 2018
  Dr. Stephenson’s presentation at University of Texas Health, San Antonio, The Perry and Ruby Stevens Parkinson’s Disease Center of Excellence: “Critical Path for Parkinson’s Collaboration to Enable Patient Focused Drug Development and Precision Medicine”

• March 11, 2018
  D-RSC presents poster on advancing drug development for Duchenne through data sharing and quantitative tool development at the 2018 MDA Clinical Conference

• March 11, 2018
  D-RSC and PSTC presented “Biomarkers for Muscle Diseases” poster at the 2018 MDA Clinical Conference

• February 20, 2018
  2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”

• December 21, 2017
  Qualitative Development and Content Validity of the Non–Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-Reported Outcome Instrument

  McCarrier K, Abraham L, Blum S, Bush E, Bushnell D, Carpenter L, Coons S, Houle C, Martin M, Mathews M, Trivedi M, Thase M, on behalf of the PRO Consortium Depression Working Group. Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure. 53rd New Clinical Drug Evaluation Unit (NCDEU): An Annual Meeting Sponsored by the American Society of Clinical Psychopharmacology (ASCP); 2013 May 28; Hollywood, FL, USA.